NASDAQ:NRSN

NeuroSense trades close to 90 cents as next $1 Nasdaq threshold comes into view
····

NeuroSense trades close to 90 cents as next $1 Nasdaq threshold comes into view

NeuroSense Therapeutics shares rose 5 cents to 87 cents Tuesday, staying below Nasdaq’s $1 minimum bid price. The company faces delisting risk, needing its stock to close above $1 and its market value to reach $35 million for 10 days by Sept. 29, 2026. NeuroSense recently raised $600,000 in a private share sale. Its ALS drug candidate, PrimeC, is set for Phase 3 trials after FDA clearance.
May 26, 2026

Stock Market Today

  • Top ASX ETFs for Retirement Investing: QUAL and QLTY
    May 28, 2026, 6:15 PM EDT. Investors seeking retirement growth may consider two quality-focused ASX-listed ETFs: VanEck MSCI International Quality ETF (ASX: QUAL) and Betashares Global Quality Leaders ETF (ASX: QLTY). QUAL holds about 300 global companies selected for high return on equity, earnings stability, and low debt, delivering a 15% yearly return over the past decade. QLTY, with 150 holdings chosen by factors including cash flow generation, offers balanced diversification and a 14% ten-year average return. Both ETFs emphasize high-quality global firms, providing potential for steady long-term earnings growth. While these funds have lower dividend yields, investors can still generate income by selling portions of their holdings. These ETFs offer a viable avenue for Australians aiming for wealth accumulation toward and during retirement.